临床研究
Copyright ©The Author(s) 2017.
世界华人消化杂志. 2017-07-18; 25(20): 1861-1868
在线出版 2017-07-18. doi: 10.11569/wcjd.v25.i20.1861
表2 77例肝癌患者血清TK1水平与临床资料的关系 (中位数, 四分位数间距)
临床资料nTK1(pmol/L)rP
性别661.620(0.918, 3.628)0.1740.131
113.310(1.390, 4.580)
年龄(岁)≤59411.420(0.840, 3.280)0.2970.009
>59363.295(1.395, 4.530)
AFP(ng/mL)≤20442.640(0.975, 4.260)-0.1650.151
>20281.420(0.940, 3.350)
HBsAg阴性391.670(0.840, 3.550)0.1200.297
阳性382.830(1.050, 3.980)
ALT(U/L)≤40571.460(0.915, 3.655)0.1770.123
>40202.975(1.573, 3.953)
AST(U/L)≤40481.440(0.858, 3.325)0.2900.011
>40293.350(1.320, 4.650)
Child-Pugh分级A级401.175(0.763, 1.938)0.5070.000
B级183.330(1.623, 4.295)
C级193.780(2.850, 4.560)
BCLC分期A100.775(0.635, 0.998)0.5030.000
B241.175(0.828, 2.003)
C203.350(1.453, 3.920)
D233.490(1.540, 4.440)
血管侵犯651.540(0.875, 3.450)0.3130.006
123.760(2.535, 4.848)
肝外器官转移601.755(0.913, 3.770)0.0940.414
171.930(0.310, 3.680)
肿瘤大小(cm)≤5581.465(0.830, 3.560)0.2950.009
>5193.310(1.950, 4.010)
肿瘤个数单发220.970(0.780, 3.293)0.2560.025
多发542.640(1.350, 3.828)

引文著录: 王芳, 崔舒, 王凤梅, 吕洪敏, 刘辉, 唐飞, 韩涛. 血清胸苷激酶1在肝癌中表达升高和BCLC分期相关. 世界华人消化杂志 2017; 25(20): 1861-1868